• Issue
    2017
    81-163
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION
Free Access

Issue Information

  • Pages: 81-83
  • First Published: 03 July 2017

REVIEW ARTICLE

Mood and neural correlates of excessive daytime sleepiness in Parkinson's disease

M.-C. Wen,  L. L. Chan,  L. C. S. Tan,  E. K. Tan, 
  • Pages: 84-96
  • First Published: 07 November 2016

ORIGINAL ARTICLE

Serum YKL-40, a prognostic marker in patients with large-artery atherosclerotic stroke

X.-L. Chen,  Q. Li,  W.-S. Huang,  Y.-S. Lin,  J. Xue,  B. Wang,  K.-L. Jin,  B. Shao, 
  • Pages: 97-102
  • First Published: 21 September 2016
ORIGINAL ARTICLE

Lack of efficacy of levetiracetam in oromandibular and cranial dystonia

J. E. Park,  P. Srivanitchapoom,  C. W. Maurer,  P. Mathew,  J. Sackett,  R. Paine,  V. L. Ramos,  M. Hallett, 
  • Pages: 103-108
  • First Published: 03 November 2016
ORIGINAL ARTICLE

Cognitive impairment and magnetic resonance imaging correlates in primary progressive multiple sclerosis

A. Gouveia,  S. P. Dias,  T. Santos,  H. Rocha,  C. R. Coelho,  L. Ruano,  O. Galego,  M. C. Diogo,  D. Seixas,  M. J. Sá,  S. Batista, 
  • Pages: 109-115
  • First Published: 24 October 2016
ORIGINAL ARTICLE

Baseline predictors of persistence to first disease-modifying treatment in multiple sclerosis

U. K. Zettl,  H. Schreiber,  U. Bauer-Steinhusen,  T. Glaser,  K. Hechenbichler,  M. Hecker,  for the BETAPATH Study Group , 
  • Pages: 116-121
  • First Published: 30 October 2016
ORIGINAL ARTICLE

Psychometric properties of the mutuality scale in Swedish dyads with Parkinson's disease

M. Karlstedt,  S. M. Fereshtehnejad,  E. Winnberg,  D. Aarsland,  J. Lökk, 
  • Pages: 122-128
  • First Published: 26 October 2016
ORIGINAL ARTICLE

Risk of Parkinson disease after organophosphate or carbamate poisoning

C.-S. Chuang,  H.-L. Su,  C.-L. Lin,  C.-H. Kao, 
  • Pages: 129-137
  • First Published: 26 October 2016
ORIGINAL ARTICLE

The efficacy of greater occipital nerve blockade in chronic migraine: A placebo-controlled study

H. L. Gul,  A. O. Ozon,  O. Karadas,  G. Koc,  L. E. Inan, 
  • Pages: 138-144
  • First Published: 02 December 2016
ORIGINAL ARTICLE

Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients

Y. Zheng,  L. Gao,  D. Wang,  D. Zang, 
  • Pages: 145-150
  • First Published: 01 November 2016
ORIGINAL ARTICLE

Quality-of-life perception by Parkinson's disease patients and caregivers

Y. Balash,  A. D. Korczyn,  J. Knaani,  A. A. Migirov,  T. Gurevich, 
  • Pages: 151-154
  • First Published: 12 January 2017
ORIGINAL ARTICLE

Triptan use in Australia 1997-2015: A pharmacoepidemiological study

B. L. K. D. Eyre,  M. J. Eadie,  M. L. van Driel,  L. Ross-Lee,  S. A. Hollingworth, 
  • Pages: 155-159
  • First Published: 16 January 2017

CLINICAL COMMENTARY

What is the “L” in LPDs? Localized as well as lateralized

E. Hartl,  J. Rémi,  C. Stoyke,  S. Noachtar, 
  • Pages: 160-163
  • First Published: 16 January 2017